1[1]James Henderson . Health Economics & Policy . Chincinnati:South - Western College Publishing, 1999, 266 ～ 89
2[2]Sherry Glied. Managed Care. in Anthony J. Culyer and Joseph P. Newhouse, eds Handbook of Health Economics, Amsterdam, New York; Elsevier, 2000, 708 ～ 53
3[3]Weiner J. P. Razing a tower of babel: a taxonomy for managed care and health insurance plans. Journal of Health Politics,PolicyandLaw, 1993, 18(1):75～103
4[5]Paul J. Feldstein. Health Policy Issues: An Economic Perspective on Health Reform(2ndedition). Chincago, IL: Health Administration Press & Washington, DC: AUPHA Press, 1999, 1993 ～ 207
5[6]Brown, L. D. Politics and Health Care Organization: HMOs as Federal Policy. Washington, D. C. Brookingslnstitution, 1983
6[7]Gruber, L. R. M. Shadle. From movement toindustry: he growth of HMOs. Health Affairs, 1988, 7(3): 197 ～ 208
7[8]Paul J. Feldstein. Health Care Economics ( fifth edition). Albany, New York: DelmarPublishers, 1998
8[9]Physician Payment Review Commission. Annual Report to Congress. Washingtion: The Commission, 1997
9[10]U.S. Department of Health & Human Services. Health United States,1998, Table 135
10[11]James C. Robinson. The Corporate Practice of Medicine - Competition and Innovation in Health Care. Berkeley and Los Angeles, California and London, England: University of California Press, 1999, 63 ～ 89
9International Trends in the Use of Health Technology Assessment. Michael Drummond, Neil Grubert. Decision Resources Inc. http://www.researchandmarkets.com/ reports/575225/.
10Health Policy Studies Pharmaceutical Pricing Policies in a Global Market. OECD,2008,9(24).
